Nisa Investment Advisors
ARRY

Nisa Investment Advisors’s Array Biopharma Inc ARRY Stock Holding History

Nisa Investment Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-118,800
Closed -$5.5M – 2092
2019
Q2 		$5.5M Hold
118,800
– – 0.05% 344
2019
Q1 		$2.9M Hold
118,800
– – 0.03% 508
2018
Q4 		$1.69M Hold
118,800
– – 0.02% 610
2018
Q3 		$1.81M Hold
118,800
– – 0.02% 703
2018
Q2 		$1.99M Hold
118,800
– – 0.02% 605
2018
Q1 		$1.94M Sell
118,800
-63,700
-35% -$1.02M 0.02% 610
2017
Q4 		$2.34M Hold
182,500
– – 0.02% 559
2017
Q3 		$2.25M Hold
182,500
– – 0.03% 550
2017
Q2 		$1.53M Buy
182,500
+630
+0.3% +$5.15K 0.02% 673
2017
Q1 		$1.63M Sell
181,870
-1,030
-0.6% -$11K 0.02% 678
2016
Q4 		$1.61M Buy
182,900
+58,200
+47% +$428K 0.02% 673
2016
Q3 		$842K Buy
124,700
+64,500
+107% +$249K 0.01% 847
2016
Q2 		$214K Buy
60,200
+57,500
+2,130% +$187K ﹤0.01% 1204
2016
Q1 		$8K Buy
+2,700
New +$8.09K ﹤0.01% 1810

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Nisa Investment Advisors's ARRY Position: Q3 2019 in Review

Nisa Investment Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 118,800 shares — an estimated $5.5M sold.

Nisa Investment Advisors first reported a position in ARRY in Q1 2016 and held it in 14 quarters. The position peaked at $5.5M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Nisa Investment Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Nisa Investment Advisors sold 118,800 Array Biopharma Inc shares in Q3 2019, an estimated $5.5M.
  • Nisa Investment Advisors first reported a position in Array Biopharma Inc in Q1 2016 and held it in 14 quarters.
  • Nisa Investment Advisors's Array Biopharma Inc position peaked at $5.5M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Nisa Investment Advisors's 13F filing for Q3 2019, filed 17 Oct 2019.